CoChat

Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension

Fukunaga, Hidefumi, Ohkubo, Takayoshi, Kobayashi, Makoto, Tamaki, Yuichiro, Kikuya, Masahiro, Obara, Taku, Nakagawa, Miwa, Hara, Azusa, Asayama, Kei, Metoki, Hirohito, Inoue, Ryusuke, Hashimoto, Junichiro, Totsune, Kazuhito, Imai, Yutaka · 2008 · Journal of Hypertension
Cited by 72

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Cost-effectiveness of hypertension treatment is an important social and medical issue in Western as well as in Eastern countries, including Japan. Home blood pressure (HBP) measurements have a stronger predictive power for cardiovascular events than casual clinic blood pressure (CBP) measurements. Therefore, the introduction of HBP measurement for the diagnosis and treatment of hypertension should lead to a decrease in medical expenditure. This study presents calculations of the cost savings likely to take place when HBP is implemented for newly detected hypertensive subjects in Japan. DESIGN AND METHODS: We estimate the cost savings from the perspective of a Japanese healthcare system. To estimate the costs associated with changing from CBP to HBP measurement as the diagnostic tool, we constructed a simulation model using data from the Ohasama study. These calculations are based on current estimates for cost of treatment, prevalence of white-coat hypertension at baseline, and varying the incidence of new hypertension after the initial screening. RESULTS: When HBP measurement is not incorporated into the diagnostic process, the medical cost is estimated at US$10.89 million per 1000 subjects per 5 years. When HBP measurement is incorporated, the medical cost is estimated at US$9.33 million per 1000 subjects per 5 years. The reductions in medical costs vary from US$674,000 to US$2.51 million per 1000 subjects per 5 years for treatment of hypertension, when sensitivity analysis is performed. CONCLUSIONS: The introduction of HBP measurement for the treatment of hypertension is very useful for reducing medical costs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e3282f42285

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 72

Metadata

Authors
Fukunaga, H., Ohkubo, T., Kobayashi, M., Tamaki, Y., Kikuya, M., Obara, T., Nakagawa, M., Hara, A., Asayama, K., Metoki, H., Inoue, R., Hashimoto, J., Totsune, K., & Imai, Y.
Venue
Journal of Hypertension
Published
2008-04
Volume
26
Issue
4
Pages
685-690
ISSN
0263-6352 (ISSN-L)
OpenAlex
W2030001676
Cited by
72
References
7
FWCI
4.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension. https://app.cochat.ai/papers/10.1097/hjh.0b013e3282f42285
The paper
Fukunaga, H., Ohkubo, T., Kobayashi, M., Tamaki, Y., Kikuya, M., Obara, T., Nakagawa, M., Hara, A., Asayama, K., Metoki, H., Inoue, R., Hashimoto, J., Totsune, K., & Imai, Y. (2008). Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e3282f42285

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.